Photo-regulated PROTACs: A novel tool for temporal control of targeted protein degradation

[Display omitted] PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin–proteasome system. These molecules catalytically degrade target proteins and sustainably inhibit their function. Therefore, PROTAC's unique mechani...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 107; pp. 129778 - 129782
Main Authors Xu, Hanqiao, Ohoka, Nobumichi, Inoue, Takao, Yokoo, Hidetomo, Demizu, Yosuke
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 15.07.2024
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract [Display omitted] PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin–proteasome system. These molecules catalytically degrade target proteins and sustainably inhibit their function. Therefore, PROTAC's unique mechanism of action is not only beneficial in medicine but also serves as a valuable tool for molecular biological analysis in fields like chemical biology, biochemistry, and drug discovery. This study presents a novel turn-off (ON-OFF) type PROTAC development strategy utilizing a photocleavable linker. The inclusion of this linker enables temporal control of the degradation activity targeting BRD4 protein upon UV light exposure. PROTAC-2 demonstrated the most potent degradation activity against BRD4 among the other synthesized PROTACs with varying linker lengths. The UV light-induced cleavage of PROTAC-2 was confirmed, leading to a reduction in its BRD4 degradation activity. Notably, this study introduces a novel linker capable of nullifying degradation activity of PROTACs which is activated by light irradiation. These findings offer a promising strategy for the development of turn-off type PROTACs, providing enhanced temporal control over protein degradation. The approach holds significant potential for applications in molecular function studies and drug discovery.
AbstractList PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin -proteasome system. These molecules catalytically degrade target proteins and sustainably inhibit their function. Therefore, PROTAC 's unique mechanism of action is not only beneficial in medicine but also serves as a valuable tool for molecular biological analysis in fields like chemical biology, biochemistry, and drug discovery. This study presents a novel turn-off (ON -OFF) type PROTAC development strategy utilizing a photocleavable linker. The inclusion of this linker enables temporal control of the degradation activity targeting BRD4 protein upon UV light exposure. PROTAC-2 demonstrated the most potent degradation activity against BRD4 among the other synthesized PROTACs with varying linker lengths. The UV light -induced cleavage of PROTAC-2 was confirmed, leading to a reduction in its BRD4 degradation activity. Notably, this study introduces a novel linker capable of nullifying degradation activity of PROTACs which is activated by light irradiation. These findings offer a promising strategy for the development of turn-off type PROTACs, providing enhanced temporal control over protein degradation. The approach holds significant potential for applications in molecular function studies and drug discovery.
PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin-proteasome system. These molecules catalytically degrade target proteins and sustainably inhibit their function. Therefore, PROTAC's unique mechanism of action is not only beneficial in medicine but also serves as a valuable tool for molecular biological analysis in fields like chemical biology, biochemistry, and drug discovery. This study presents a novel turn-off (ON-OFF) type PROTAC development strategy utilizing a photocleavable linker. The inclusion of this linker enables temporal control of the degradation activity targeting BRD4 protein upon UV light exposure. PROTAC-2 demonstrated the most potent degradation activity against BRD4 among the other synthesized PROTACs with varying linker lengths. The UV light-induced cleavage of PROTAC-2 was confirmed, leading to a reduction in its BRD4 degradation activity. Notably, this study introduces a novel linker capable of nullifying degradation activity of PROTACs which is activated by light irradiation. These findings offer a promising strategy for the development of turn-off type PROTACs, providing enhanced temporal control over protein degradation. The approach holds significant potential for applications in molecular function studies and drug discovery.PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin-proteasome system. These molecules catalytically degrade target proteins and sustainably inhibit their function. Therefore, PROTAC's unique mechanism of action is not only beneficial in medicine but also serves as a valuable tool for molecular biological analysis in fields like chemical biology, biochemistry, and drug discovery. This study presents a novel turn-off (ON-OFF) type PROTAC development strategy utilizing a photocleavable linker. The inclusion of this linker enables temporal control of the degradation activity targeting BRD4 protein upon UV light exposure. PROTAC-2 demonstrated the most potent degradation activity against BRD4 among the other synthesized PROTACs with varying linker lengths. The UV light-induced cleavage of PROTAC-2 was confirmed, leading to a reduction in its BRD4 degradation activity. Notably, this study introduces a novel linker capable of nullifying degradation activity of PROTACs which is activated by light irradiation. These findings offer a promising strategy for the development of turn-off type PROTACs, providing enhanced temporal control over protein degradation. The approach holds significant potential for applications in molecular function studies and drug discovery.
[Display omitted] PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin–proteasome system. These molecules catalytically degrade target proteins and sustainably inhibit their function. Therefore, PROTAC's unique mechanism of action is not only beneficial in medicine but also serves as a valuable tool for molecular biological analysis in fields like chemical biology, biochemistry, and drug discovery. This study presents a novel turn-off (ON-OFF) type PROTAC development strategy utilizing a photocleavable linker. The inclusion of this linker enables temporal control of the degradation activity targeting BRD4 protein upon UV light exposure. PROTAC-2 demonstrated the most potent degradation activity against BRD4 among the other synthesized PROTACs with varying linker lengths. The UV light-induced cleavage of PROTAC-2 was confirmed, leading to a reduction in its BRD4 degradation activity. Notably, this study introduces a novel linker capable of nullifying degradation activity of PROTACs which is activated by light irradiation. These findings offer a promising strategy for the development of turn-off type PROTACs, providing enhanced temporal control over protein degradation. The approach holds significant potential for applications in molecular function studies and drug discovery.
ArticleNumber 129778
Author Yokoo, Hidetomo
Demizu, Yosuke
Xu, Hanqiao
Inoue, Takao
Ohoka, Nobumichi
Author_xml – sequence: 1
  givenname: Hanqiao
  surname: Xu
  fullname: Xu, Hanqiao
  organization: Graduate School of Medical Life Science, Yokohama City University, 1-7-29, Yokohama, Kanagawa 230-0045, Japan
– sequence: 2
  givenname: Nobumichi
  surname: Ohoka
  fullname: Ohoka, Nobumichi
  email: n-ohoka@nihs.go.jp
  organization: Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan
– sequence: 3
  givenname: Takao
  surname: Inoue
  fullname: Inoue, Takao
  organization: Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan
– sequence: 4
  givenname: Hidetomo
  surname: Yokoo
  fullname: Yokoo, Hidetomo
  email: yokoo@nihs.go.jp
  organization: Division of Organic Chemistry, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan
– sequence: 5
  givenname: Yosuke
  orcidid: 0000-0001-7521-4861
  surname: Demizu
  fullname: Demizu, Yosuke
  email: demizu@nihs.go.jp
  organization: Graduate School of Medical Life Science, Yokohama City University, 1-7-29, Yokohama, Kanagawa 230-0045, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38702019$$D View this record in MEDLINE/PubMed
BookMark eNqNkF1rFDEUQIO02G31D_gg8yjIbPM1k4n4sgy2CoUWqSC-hEzmZp1lJlmTTMV_b9ZZ-1ialwvhnMvlnKMT5x0g9IbgNcGkvtytu8mMa4opXxMqhWheoBXhNS8Zx9UJWmFZ47KR_PsZOo9xhzHhmPOX6Iw1AlNM5Ar9uPvpky8DbOdRJ-iLu6-395s2fig2hfMPMBbJ-7GwPhQJpr0PeiyMdynkT2-LpMMWDto--ASDK3rYBt3rNHj3Cp1aPUZ4fZwX6NvVp_v2c3lze_2l3dyUhgmWSg4NowJq0tW81zXrrOVGSlMBt0KzimBrRUMEZXWltRTMEspl14A0Vuq-Yxfo3bI33_BrhpjUNEQD46gd-DkqhissmZREZvTtEZ27CXq1D8Okwx_1v0cG6AKY4GMMYB8RgtUhutqpQ3R1iK6W6FlqFuk3dN5GM4Az8Cjm6jTvF6TB-ZF2SP_qtH52Kavvn69m-uNCQ875MEBQR6MfApikej88dedfw_OqiA
Cites_doi 10.1039/d2cs00193d
10.1021/acscentsci.9b00713
10.1002/cmdc.202300530
10.1039/c5py00562k
10.1016/j.molcel.2021.01.023
10.1039/d2cc03092f
10.1038/s41589-018-0055-y
10.1021/jacs.9b12718
10.1016/j.molcel.2017.06.004
10.1016/j.cbpa.2022.102148
10.1007/s40265-013-0047-x
10.1126/sciadv.aay5154
10.1016/j.scib.2023.04.028
10.1002/anie.202306824
10.3389/fcell.2021.678077
10.1021/acs.jmedchem.9b02058
10.1007/s13238-020-00732-8
10.1021/acs.jcim.8b00872
10.1039/d2cc03367d
10.1021/acs.jcim.0c00897
10.31635/ccschem.022.202101529
10.1039/d0cc00523a
10.1039/D0CC00523A
10.1039/D2CS00193D
10.1039/D2CC03092F
10.1039/D2CC03367D
10.1039/C5PY00562K
ContentType Journal Article
Copyright 2024 Elsevier Ltd
Copyright © 2024 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2024 Elsevier Ltd
– notice: Copyright © 2024 Elsevier Ltd. All rights reserved.
DBID 17B
1KM
BLEPL
DTL
EGQ
AAYXX
CITATION
NPM
7X8
DOI 10.1016/j.bmcl.2024.129778
DatabaseName Web of Knowledge
Index Chemicus
Web of Science Core Collection
Science Citation Index Expanded
Web of Science Primary (SCIE, SSCI & AHCI)
CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle Web of Science
CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList Web of Science
PubMed
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Chemistry
EISSN 1464-3405
ExternalDocumentID 38702019
10_1016_j_bmcl_2024_129778
001238771800001
S0960894X2400180X
Genre Journal Article
GrantInformation_xml – fundername: Grants-in-Aid for Scientific Research; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research (KAKENHI)
  grantid: 21K06490; 22K15257
– fundername: Japan Society for the Promotion of Science (KAKENHI); Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research (KAKENHI)
  grantid: JP21K05320; JP23H04926; JP22K15257; JP18K06567; JP21K06490
– fundername: AMED
  grantid: 23fk0210110; 23fk0310506; 23ak0101186; 23fk0310504
– fundername: Takeda Science Foundation; Takeda Science Foundation (TSF)
– fundername: Kowa Life Science Foundation
– fundername: JST, the establishment of university fellowships towards the creation of science technology innovation
  grantid: JPMJFS2140
– fundername: JST (ACT-X)
  grantid: JPMJAX222L
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
5GY
5VS
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARLI
AAXUO
ABBQC
ABFNM
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABUDA
ABZDS
ACDAQ
ACGFS
ACIUM
ACRLP
ADBBV
ADECG
ADEZE
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJSZI
AKRWK
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CS3
D0L
EBS
EFJIC
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FLBIZ
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPC
SPCBC
SSH
SSK
SSP
SSU
SSZ
T5K
YK3
ZMT
~02
~G-
17B
1KM
AATTM
AAXKI
AAYWO
ACIEU
ACVFH
ADCNI
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGRNS
AIGII
AIIUN
AKBMS
AKYEP
ANKPU
APXCP
BLEPL
DTL
EFKBS
GROUPED_WOS_WEB_OF_SCIENCE
LZ2
M29
M2Z
M34
.HR
53G
6TJ
AAQXK
AAYXX
ABWVN
ABXDB
ACNNM
ACRPL
ADMUD
ADNMO
ADXHL
AFFNX
AGQPQ
AGRDE
AHHHB
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
FGOYB
G-2
HEA
HMK
HMO
HMS
HMT
HVGLF
HZ~
R2-
SAE
SCB
SOC
SPT
WUQ
XPP
Y6R
ZY4
NPM
7X8
ID FETCH-LOGICAL-c373t-4e8327e61b64da63bff4c99c5e4f7a3510ff78172365aa973f1249b8e9cf9adb3
IEDL.DBID .~1
ISICitedReferencesCount 2
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=001238771800001
ISSN 0960-894X
1464-3405
IngestDate Mon Jul 21 09:50:06 EDT 2025
Mon Jul 21 06:05:00 EDT 2025
Thu Jul 03 08:46:09 EDT 2025
Tue Jul 22 04:47:47 EDT 2025
Fri Aug 29 16:13:57 EDT 2025
Sat Jun 01 15:40:37 EDT 2024
IsPeerReviewed true
IsScholarly true
Keywords Turn-off type
Chemical tool
PROTAC
Photocleavable linker
Photo-caged group
Language English
License Copyright © 2024 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-c373t-4e8327e61b64da63bff4c99c5e4f7a3510ff78172365aa973f1249b8e9cf9adb3
Notes KAKEN
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-7521-4861
PMID 38702019
PQID 3050939919
PQPubID 23479
PageCount 5
ParticipantIDs webofscience_primary_001238771800001
proquest_miscellaneous_3050939919
webofscience_primary_001238771800001CitationCount
crossref_primary_10_1016_j_bmcl_2024_129778
elsevier_sciencedirect_doi_10_1016_j_bmcl_2024_129778
pubmed_primary_38702019
PublicationCentury 2000
PublicationDate 2024-07-15
PublicationDateYYYYMMDD 2024-07-15
PublicationDate_xml – month: 07
  year: 2024
  text: 2024-07-15
  day: 15
PublicationDecade 2020
PublicationPlace OXFORD
PublicationPlace_xml – name: OXFORD
– name: England
PublicationTitle Bioorganic & medicinal chemistry letters
PublicationTitleAbbrev BIOORG MED CHEM LETT
PublicationTitleAlternate Bioorg Med Chem Lett
PublicationYear 2024
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Drummond, Henry, Li, Williams (b0105) 2020; 60
Li, Crews (b0005) 2022; 51
Schwalm, Knapp (b0090) 2022; 68
An, Deng, Chi (b0040) 2023; 62
Kaiho-Soma, Akizuki, Igarashi (b0010) 2021; 81
Liang, Zheng, Luo, Cai, Mao, Wang (b0030) 2022; 4
Winter, Mayer, Buckley (b0080) 2017; 67
Kounde, Shchepinova, Saunders (b0065) 2020; 56
Zhang, Kounde, Mondal (b0050) 2022; 58
Hu, Shi, Thomas (b0095) 2015; 6
Liu, Chen, Ma (b0075) 2020; 6
Naro, Darrah, Deiters (b0060) 2020; 142
Drummond, Williams (b0100) 2019; 59
Gao, Zheng, Du (b0015) 2020; 11
Gao, Yang, Lei (b0035) 2023; 68
Pfaff, Samarasinghe, Crews, Carreira (b0045) 2019; 5
Liu, Peng, Wei (b0055) 2021; 9
Liu, Ren, Sun (b0025) 2022; 58
Zhao, Narjes (b0020) 2023; 18
Jin, Lu, Wang (b0070) 2020; 63
Elkinson, McCormack (b0085) 2013; 73
Nowak, DeAngelo, Buckley (b0110) 2018; 14
Liu, J (WOS:000680366500001) 2021; 9
Zhao, HT (WOS:001100700000001) 2023; 18
Liu, J (WOS:000514842000021) 2020; 6
Schwalm, MP (WOS:000800101400002) 2022; 68
Liang, CJ (WOS:000908427000015) 2022; 4
Jin, YH (WOS:000535279800017) 2020; 63
Drummond, ML (WOS:000586716900072) 2020; 60
Naro, Y (WOS:000512222700020) 2020; 142
Gao, HY (WOS:000535447000001) 2020; 11
Elkinson, S (WOS:000318574200008) 2013; 73
Hu, XR (WOS:000357163800013) 2015; 6
Drummond, ML (WOS:000465644500033) 2019; 59
Pfaff, P (WOS:000492698300011) 2019; 5
Nowak, RP (WOS:000435446600016) 2018; 14
Li, K (WOS:000807096700001) 2022; 51
Zhang, QS (WOS:000850258400001) 2022; 58
Gao, J (WOS:001019160200001) 2023; 68
Winter, GE (WOS:000404897300003) 2017; 67
Kaiho-Soma, A (WOS:000637214700010) 2021; 81
Kounde, CS (WOS:000536127800013) 2020; 56
Liu, HX (WOS:000842605800001) 2022; 58
An, KL (WOS:001048928600001) 2023; 62
Naro (10.1016/j.bmcl.2024.129778_b0060) 2020; 142
Nowak (10.1016/j.bmcl.2024.129778_b0110) 2018; 14
Schwalm (10.1016/j.bmcl.2024.129778_b0090) 2022; 68
Pfaff (10.1016/j.bmcl.2024.129778_b0045) 2019; 5
Liu (10.1016/j.bmcl.2024.129778_b0055) 2021; 9
Liu (10.1016/j.bmcl.2024.129778_b0025) 2022; 58
Gao (10.1016/j.bmcl.2024.129778_b0035) 2023; 68
Kounde (10.1016/j.bmcl.2024.129778_b0065) 2020; 56
Hu (10.1016/j.bmcl.2024.129778_b0095) 2015; 6
Kaiho-Soma (10.1016/j.bmcl.2024.129778_b0010) 2021; 81
Li (10.1016/j.bmcl.2024.129778_b0005) 2022; 51
Drummond (10.1016/j.bmcl.2024.129778_b0105) 2020; 60
Jin (10.1016/j.bmcl.2024.129778_b0070) 2020; 63
Zhao (10.1016/j.bmcl.2024.129778_b0020) 2023; 18
Drummond (10.1016/j.bmcl.2024.129778_b0100) 2019; 59
Winter (10.1016/j.bmcl.2024.129778_b0080) 2017; 67
Gao (10.1016/j.bmcl.2024.129778_b0015) 2020; 11
Liang (10.1016/j.bmcl.2024.129778_b0030) 2022; 4
Zhang (10.1016/j.bmcl.2024.129778_b0050) 2022; 58
An (10.1016/j.bmcl.2024.129778_b0040) 2023; 62
Liu (10.1016/j.bmcl.2024.129778_b0075) 2020; 6
Elkinson (10.1016/j.bmcl.2024.129778_b0085) 2013; 73
References_xml – volume: 58
  start-page: 10933
  year: 2022
  end-page: 10936
  ident: b0050
  publication-title: Chem Commun (Camb)
– volume: 68
  start-page: 1069
  year: 2023
  end-page: 1085
  ident: b0035
  publication-title: Sci Bull (beijing)
– volume: 62
  start-page: e202306824
  year: 2023
  ident: b0040
  publication-title: Angew Chem Int Ed Engl
– volume: 142
  start-page: 2193
  year: 2020
  end-page: 2197
  ident: b0060
  publication-title: J Am Chem Soc
– volume: 11
  start-page: 534
  year: 2020
  end-page: 539
  ident: b0015
  publication-title: Protein Cell
– volume: 5
  start-page: 1682
  year: 2019
  end-page: 1690
  ident: b0045
  publication-title: ACS Cent Sci
– volume: 67
  start-page: e19
  year: 2017
  ident: b0080
  publication-title: Mol Cell
– volume: 6
  start-page: 4966
  year: 2015
  end-page: 4971
  ident: b0095
  publication-title: Polym Chem
– volume: 63
  start-page: 4644
  year: 2020
  end-page: 4654
  ident: b0070
  publication-title: J Med Chem
– volume: 60
  start-page: 5234
  year: 2020
  end-page: 5254
  ident: b0105
  publication-title: J Chem Inf Model
– volume: 14
  start-page: 706
  year: 2018
  end-page: 714
  ident: b0110
  publication-title: Nat Chem Biol
– volume: 4
  start-page: 3809
  year: 2022
  end-page: 3819
  ident: b0030
  publication-title: CCS Chemistry
– volume: 56
  start-page: 5532
  year: 2020
  end-page: 5535
  ident: b0065
  publication-title: Chem Commun (Camb)
– volume: 6
  start-page: 5154
  year: 2020
  ident: b0075
  publication-title: Sci Adv
– volume: 81
  start-page: e1417
  year: 2021
  ident: b0010
  publication-title: Mol Cell
– volume: 9
  year: 2021
  ident: b0055
  publication-title: Front Cell Dev Biol
– volume: 73
  start-page: 595
  year: 2013
  end-page: 604
  ident: b0085
  publication-title: Drugs
– volume: 59
  start-page: 1634
  year: 2019
  end-page: 1644
  ident: b0100
  publication-title: J Chem Inf Model
– volume: 18
  start-page: e202300530
  year: 2023
  ident: b0020
  publication-title: ChemMedChem
– volume: 68
  year: 2022
  ident: b0090
  publication-title: Curr Opin Chem Biol
– volume: 51
  start-page: 5214
  year: 2022
  end-page: 5236
  ident: b0005
  publication-title: Chem Soc Rev
– volume: 58
  start-page: 10072
  year: 2022
  end-page: 10075
  ident: b0025
  publication-title: Chem Commun (Camb)
– volume: 51
  start-page: 5214
  year: 2022
  ident: WOS:000807096700001
  article-title: PROTACs: past, present and future
  publication-title: CHEMICAL SOCIETY REVIEWS
  doi: 10.1039/d2cs00193d
– volume: 5
  start-page: 1682
  year: 2019
  ident: WOS:000492698300011
  article-title: Reversible Spatiotemporal Control of Induced Protein Degradation by Bistable PhotoPROTACs
  publication-title: ACS CENTRAL SCIENCE
  doi: 10.1021/acscentsci.9b00713
– volume: 18
  year: 2023
  ident: WOS:001100700000001
  article-title: Kinetic Modeling of PROTAC-Induced Protein Degradation
  publication-title: CHEMMEDCHEM
  doi: 10.1002/cmdc.202300530
– volume: 6
  start-page: 4966
  year: 2015
  ident: WOS:000357163800013
  article-title: Photolabile ROMP gels using ortho-nitrobenzyl functionalized crosslinkers
  publication-title: POLYMER CHEMISTRY
  doi: 10.1039/c5py00562k
– volume: 81
  start-page: 1411
  year: 2021
  ident: WOS:000637214700010
  article-title: TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains
  publication-title: MOLECULAR CELL
  doi: 10.1016/j.molcel.2021.01.023
– volume: 58
  start-page: 10933
  year: 2022
  ident: WOS:000850258400001
  article-title: Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP- PROTACs)
  publication-title: CHEMICAL COMMUNICATIONS
  doi: 10.1039/d2cc03092f
– volume: 14
  start-page: 706
  year: 2018
  ident: WOS:000435446600016
  article-title: Plasticity in binding confers selectivity in ligand-induced protein degradation
  publication-title: NATURE CHEMICAL BIOLOGY
  doi: 10.1038/s41589-018-0055-y
– volume: 142
  start-page: 2193
  year: 2020
  ident: WOS:000512222700020
  article-title: Optical Control of Small Molecule-Induced Protein Degradation
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.9b12718
– volume: 67
  start-page: 5
  year: 2017
  ident: WOS:000404897300003
  article-title: BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment
  publication-title: MOLECULAR CELL
  doi: 10.1016/j.molcel.2017.06.004
– volume: 68
  start-page: ARTN 102148
  year: 2022
  ident: WOS:000800101400002
  article-title: BET bromodomain inhibitors
  publication-title: CURRENT OPINION IN CHEMICAL BIOLOGY
  doi: 10.1016/j.cbpa.2022.102148
– volume: 73
  start-page: 595
  year: 2013
  ident: WOS:000318574200008
  article-title: Pomalidomide: First Global Approval
  publication-title: DRUGS
  doi: 10.1007/s40265-013-0047-x
– volume: 6
  start-page: ARTN eaay5154
  year: 2020
  ident: WOS:000514842000021
  article-title: Light-induced control of protein destruction by opto-PROTAC
  publication-title: SCIENCE ADVANCES
  doi: 10.1126/sciadv.aay5154
– volume: 68
  start-page: 1069
  year: 2023
  ident: WOS:001019160200001
  article-title: Stimuli-activatable PROTACs for precise protein degradation and cancer therapy
  publication-title: SCIENCE BULLETIN
  doi: 10.1016/j.scib.2023.04.028
– volume: 62
  year: 2023
  ident: WOS:001048928600001
  article-title: Stimuli-Responsive PROTACs for Controlled Protein Degradation
  publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
  doi: 10.1002/anie.202306824
– volume: 9
  start-page: ARTN 678077
  year: 2021
  ident: WOS:000680366500001
  article-title: Light-Controllable PROTACs for Temporospatial Control of Protein Degradation
  publication-title: FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
  doi: 10.3389/fcell.2021.678077
– volume: 63
  start-page: 4644
  year: 2020
  ident: WOS:000535279800017
  article-title: Azo-PROTAC: Novel Light-Controlled Small-Molecule Tool for Protein Knockdown
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/acs.jmedchem.9b02058
– volume: 11
  start-page: 534
  year: 2020
  ident: WOS:000535447000001
  article-title: FAK-targeting PROTAC as a chemical tool for the investigation of non-enzymatic FAK function in mice
  publication-title: PROTEIN & CELL
  doi: 10.1007/s13238-020-00732-8
– volume: 59
  start-page: 1634
  year: 2019
  ident: WOS:000465644500033
  article-title: In Silico Modeling of PROTAC-Mediated Ternary Complexes: Validation and Application
  publication-title: JOURNAL OF CHEMICAL INFORMATION AND MODELING
  doi: 10.1021/acs.jcim.8b00872
– volume: 58
  start-page: 10072
  year: 2022
  ident: WOS:000842605800001
  article-title: Reactive oxygen species-responsive Pre-PROTAC for tumor-specific protein degradation
  publication-title: CHEMICAL COMMUNICATIONS
  doi: 10.1039/d2cc03367d
– volume: 60
  start-page: 5234
  year: 2020
  ident: WOS:000586716900072
  article-title: Improved Accuracy for Modeling PROTAC-Mediated Ternary Complex Formation and Targeted Protein Degradation via New In Silico Methodologies
  publication-title: JOURNAL OF CHEMICAL INFORMATION AND MODELING
  doi: 10.1021/acs.jcim.0c00897
– volume: 4
  start-page: 3809
  year: 2022
  ident: WOS:000908427000015
  article-title: Enzyme-Catalyzed Activation of Pro-PROTAC for Cell-Selective Protein Degradation
  publication-title: CCS CHEMISTRY
  doi: 10.31635/ccschem.022.202101529
– volume: 56
  start-page: 5532
  year: 2020
  ident: WOS:000536127800013
  article-title: A caged E3 ligase ligand for PROTAC-mediated protein degradation with light
  publication-title: CHEMICAL COMMUNICATIONS
  doi: 10.1039/d0cc00523a
– volume: 11
  start-page: 534
  year: 2020
  ident: 10.1016/j.bmcl.2024.129778_b0015
  publication-title: Protein Cell
  doi: 10.1007/s13238-020-00732-8
– volume: 6
  start-page: 5154
  year: 2020
  ident: 10.1016/j.bmcl.2024.129778_b0075
  publication-title: Sci Adv
  doi: 10.1126/sciadv.aay5154
– volume: 56
  start-page: 5532
  year: 2020
  ident: 10.1016/j.bmcl.2024.129778_b0065
  publication-title: Chem Commun (Camb)
  doi: 10.1039/D0CC00523A
– volume: 63
  start-page: 4644
  year: 2020
  ident: 10.1016/j.bmcl.2024.129778_b0070
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.9b02058
– volume: 51
  start-page: 5214
  year: 2022
  ident: 10.1016/j.bmcl.2024.129778_b0005
  publication-title: Chem Soc Rev
  doi: 10.1039/D2CS00193D
– volume: 9
  year: 2021
  ident: 10.1016/j.bmcl.2024.129778_b0055
  publication-title: Front Cell Dev Biol
– volume: 59
  start-page: 1634
  year: 2019
  ident: 10.1016/j.bmcl.2024.129778_b0100
  publication-title: J Chem Inf Model
  doi: 10.1021/acs.jcim.8b00872
– volume: 60
  start-page: 5234
  year: 2020
  ident: 10.1016/j.bmcl.2024.129778_b0105
  publication-title: J Chem Inf Model
  doi: 10.1021/acs.jcim.0c00897
– volume: 68
  start-page: 1069
  year: 2023
  ident: 10.1016/j.bmcl.2024.129778_b0035
  publication-title: Sci Bull (beijing)
  doi: 10.1016/j.scib.2023.04.028
– volume: 81
  start-page: e1417
  year: 2021
  ident: 10.1016/j.bmcl.2024.129778_b0010
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2021.01.023
– volume: 58
  start-page: 10933
  year: 2022
  ident: 10.1016/j.bmcl.2024.129778_b0050
  publication-title: Chem Commun (Camb)
  doi: 10.1039/D2CC03092F
– volume: 5
  start-page: 1682
  year: 2019
  ident: 10.1016/j.bmcl.2024.129778_b0045
  publication-title: ACS Cent Sci
  doi: 10.1021/acscentsci.9b00713
– volume: 62
  start-page: e202306824
  year: 2023
  ident: 10.1016/j.bmcl.2024.129778_b0040
  publication-title: Angew Chem Int Ed Engl
  doi: 10.1002/anie.202306824
– volume: 142
  start-page: 2193
  year: 2020
  ident: 10.1016/j.bmcl.2024.129778_b0060
  publication-title: J Am Chem Soc
  doi: 10.1021/jacs.9b12718
– volume: 68
  year: 2022
  ident: 10.1016/j.bmcl.2024.129778_b0090
  publication-title: Curr Opin Chem Biol
  doi: 10.1016/j.cbpa.2022.102148
– volume: 18
  start-page: e202300530
  year: 2023
  ident: 10.1016/j.bmcl.2024.129778_b0020
  publication-title: ChemMedChem
  doi: 10.1002/cmdc.202300530
– volume: 67
  start-page: e19
  year: 2017
  ident: 10.1016/j.bmcl.2024.129778_b0080
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2017.06.004
– volume: 73
  start-page: 595
  year: 2013
  ident: 10.1016/j.bmcl.2024.129778_b0085
  publication-title: Drugs
  doi: 10.1007/s40265-013-0047-x
– volume: 58
  start-page: 10072
  year: 2022
  ident: 10.1016/j.bmcl.2024.129778_b0025
  publication-title: Chem Commun (Camb)
  doi: 10.1039/D2CC03367D
– volume: 6
  start-page: 4966
  year: 2015
  ident: 10.1016/j.bmcl.2024.129778_b0095
  publication-title: Polym Chem
  doi: 10.1039/C5PY00562K
– volume: 14
  start-page: 706
  year: 2018
  ident: 10.1016/j.bmcl.2024.129778_b0110
  publication-title: Nat Chem Biol
  doi: 10.1038/s41589-018-0055-y
– volume: 4
  start-page: 3809
  year: 2022
  ident: 10.1016/j.bmcl.2024.129778_b0030
  publication-title: CCS Chemistry
  doi: 10.31635/ccschem.022.202101529
SSID ssj0014044
Score 2.444227
Snippet [Display omitted] PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin–proteasome...
PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin -proteasome system. These...
PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin-proteasome system. These...
Source Web of Science
SourceID proquest
pubmed
crossref
webofscience
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 129778
SubjectTerms Chemical tool
Chemistry
Chemistry, Medicinal
Chemistry, Organic
Life Sciences & Biomedicine
Pharmacology & Pharmacy
Photo-caged group
Photocleavable linker
Physical Sciences
PROTAC
Science & Technology
Turn-off type
Title Photo-regulated PROTACs: A novel tool for temporal control of targeted protein degradation
URI https://dx.doi.org/10.1016/j.bmcl.2024.129778
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=001238771800001
https://www.ncbi.nlm.nih.gov/pubmed/38702019
https://www.proquest.com/docview/3050939919
Volume 107
WOS 001238771800001
WOSCitedRecordID wos001238771800001
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9UwFD6MCeqL6J0_rtMRYfgi2V2bpGl8K8VxVTaHbnDxpSRtwq7ctWPrBr74t3uSphfFIeJjm6SkOck5X3JOvgOw26TO5Mw4KkXtKM8Vp2o_NzRFW5wJm2gdGPgOj7L5Kf-wEIsNKMe7MD6sMur-QacHbR3fzOJozi6Wy9kXD77x2wsfBZnk-wt_g51LP8v3fqzDPDx7TKCQwsrU144XZ4YYL3Nee_dDyvfQ7Emfau124_Qn-LzVTgWbdPAQHkQwSYqhv49gw7YT2Cpa3EiffyevSQjvDOfmE7hXjqndJnD3MHrUt-Dr8VnXd_RySElvG3L8-dNJUV69JQVpuxu7In3XrQhCWxJZrFYkhreTzpEhkBybBb6HZUsaTz4x5Gl6DKcH707KOY35FmjNJOspt7i8pc0Sk_FGZyhBx2ulamG5k5rh6nVO5oh4WCa0VpI5n7na5FbVTunGsCew2XatfQbEWF7blDuumeJOGZU5wSRuepM0sbXQU3gzDnR1MdBqVGO82bfKi6XyYqkGsUxBjLKofpscFer9v7Z7NQquwhH2rhDd2u76qmKe9gaxWaKm8HSQ6LofDFUYwiIs2f1VxOvyAENziUY9uEamkPxLtTJSrnuqgf75f_7QNtz3T_5sOREvYLO_vLYvERT1ZifM-h24U7z_OD_6CerpCS4
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6NTmK8oNHxozDASBMvKLSJ7STeWxQxdWwtE3RSxYtlJ7Yo6pJpy5D473dOnArEhBCvcRw5_uK7L77zdwAHZWR1SrUNEl7YgKWCBWKS6iBCXxxzEyrVKvDN5vH0nH1c8uUW5P1ZGJdW6W1_Z9Nba-2vjP1sji9Xq_EXR77x2UuXBRmmk-U92HbqVHwA29nxyXS-CSawSVvT1d0fuA7-7EyX5qUvCheBiNh79HyJq7Z2t3_6k3_e6apat3S0Cw89nyRZN-RHsGWqIexlFf5LX_wkb0mb4dlunQ9hJ--ruw3h_swH1ffg69m3uqmDq64qvSnJ2edPiyy_PiQZqeofZk2aul4TZLfEC1mtic9wJ7UlXS45dmslH1YVKZ3-RFeq6TGcH31Y5NPAl1wICprQJmAGV3hi4lDHrFQxgmhZIUTBDbOJoriArU1SJD005kqJhFpXvFqnRhRWqFLTJzCo6so8A6INK0zELFNUMCu0iC2nCf73hlFoCq5G8K6faHnZKWvIPuXsu3SwSAeL7GAZAe-xkL99HxJN_1_7vemBkzjDLhqiKlPfXEvqlG-QnoViBE87RDfjoGjFkBlhy8GvEG_aWyaaJujX2-jICMJ_uS33qutObaB5_p8v9Bp2povZqTw9np-8gAeuxW01h3wfBs3VjXmJHKnRr_wauAX9sgvf
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Photo-regulated+PROTACs%3A+A+novel+tool+for+temporal+control+of+targeted+protein+degradation&rft.jtitle=Bioorganic+%26+medicinal+chemistry+letters&rft.au=Xu%2C+Hanqiao&rft.au=Ohoka%2C+Nobumichi&rft.au=Yokoo%2C+Hidetomo&rft.au=Demizu%2C+Yosuke&rft.date=2024-07-15&rft.pub=Elsevier&rft.issn=0960-894X&rft.eissn=1464-3405&rft.volume=107&rft_id=info:doi/10.1016%2Fj.bmcl.2024.129778&rft_id=info%3Apmid%2F38702019&rft.externalDBID=n%2Fa&rft.externalDocID=001238771800001
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-894X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-894X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-894X&client=summon